Delving into the Latest Updates on Allerderm Laboratories, Inc. with Synapse

概览

关联

1

项与 Allerderm Laboratories, Inc. 相关的药物

Lyral(Allerderm)

靶点-

作用机制

免疫调节剂

在研机构-

原研机构

Allerderm Laboratories, Inc.

在研适应症-

非在研适应症

接触性皮炎

最高研发阶段无进展

首次获批国家/地区-

首次获批日期-

11

项与 Allerderm Laboratories, Inc. 相关的临床试验

NCT04500834 / Recruiting临床3期

Clinical Evaluation of Metal Panel Allergens: Safety and Efficacy Study

Metal allergen patch test study.

开始日期2022-02-07

申办/合作机构

Allerderm Laboratories, Inc.

NCT02615249 / Completed临床2期

Clinical Evaluation of Metal Panel Allergens: Aluminum, Copper, Manganese, Molybdenum, Tin, Titanium, Vanadium and Zinc Dose Response Study

48-hour application of metal allergen patches to test for potential allergic responses.

开始日期2016-12-05

申办/合作机构

Allerderm Laboratories, Inc.

NCT02028208 / Completed临床2期

Clinical Evaluation of Metal Panel Allergens: Mercury, Aluminum and Palladium Dose Response Study

The purpose of this study is to evaluate the diagnostic performance and safety of ascending doses of mercury, aluminum and palladium metal allergens proposed for inclusion in a metal allergen panel. Optimal dose will be selected based on the lowest dose of each allergen eliciting a positive response in 70-90% of subjects tested.

开始日期2013-11-04

申办/合作机构

Allerderm Laboratories, Inc.

100 项与 Allerderm Laboratories, Inc. 相关的临床结果

登录后查看更多信息

0 项与 Allerderm Laboratories, Inc. 相关的专利（医药）

登录后查看更多信息

100 项与 Allerderm Laboratories, Inc. 相关的药物交易

登录后查看更多信息

100 项与 Allerderm Laboratories, Inc. 相关的转化医学

登录后查看更多信息